Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 564.50
Bid: 563.50
Ask: 566.50
Change: -5.50 (-0.96%)
Spread: 3.00 (0.532%)
Open: 569.00
High: 569.00
Low: 560.00
Prev. Close: 570.00
DRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2022 Performance Awards - EPS Condition

19 Apr 2022 12:00

RNS Number : 5995I
Drax Group PLC
19 April 2022
 

19 April 2022

Drax Group plc

("Drax" or the "Group"; Symbol:DRX)

 

2022 Performance Awards - EPS Condition

At the time of publishing the annual report for the financial year ended 31 December 2021, Drax advised it would be separately determining, and thereafter releasing details of, the Cumulative Adjusted Earnings per Share performance condition which applies to grants made to PDMRs and other employees in the 2022 financial year.

The vesting of awards granted are subject to satisfying two performance criteria over the financial years 2022, 2023 and 2024. 50% of the awards will be measured based on Relative Total Shareholder Return relative to the FTSE-350, and the remaining 50% will be measured based on Cumulative Adjusted Earnings per Share.

Following a meeting of the Remuneration Committee, the proposed Cumulative Adjusted EPS target for 2022 has been agreed. The EPS target was set after considering the company's internal forecasts, market expectations and sector peers.

 

 

Threshold

Target

Maximum

239.5p

266.1p

292.7p

 

 

BASIS OF VESTING

Performance

Target

% of Award Vesting(of EPS performance condition)

Below threshold

0%

Threshold

239.5p

25%

Maximum

292.7p

100%

 

Vesting between the threshold and maximum will be on a straight-line basis.

The EPS target is 'Adjusted EPS', derived from Adjusted Results as reported in the Company's audited financial statements. Instances where such adjustments might apply include acquisition and restructuring costs, asset obsolescence charges and certain remeasurements on derivative contracts.

There may arise circumstances during the performance period where adjustment or discretion is applied by the Remuneration Committee by reference to exceptional items and the Remuneration Policy. The application of such adjustments would be considered during and upon completion of the performance cycle. In making their assessment, the Remuneration Committee will take into account appropriate advice (for example from our auditors, Remuneration Committee advisers or the Audit Committee) and also give due consideration to the shareholder experience. The Remuneration Committee would also take into account exceptional and unforeseen circumstances, including wider considerations such as the prevailing market environment, in assessing the appropriate level of vesting judged against the performance of the Company and management at the end of the performance period.

Total Shareholder Return relative to the FTSE-350 will be measured over the three-year period (2022-2024) consistent with the approach previously approved by shareholders.

The Remuneration Committee of Drax considers that attaining outturn at the top end of the range would represent strong performance considering the uncertain economic circumstances and the challenges to the broader economy. 

 

Ends

 

Enquiries:

Drax Investor Relations: Mark Strafford

mark.strafford@drax.com 

+44 (0) 7730 763 949

Brett Gladden, Group Company Secretarybrett.gladden@drax.com+44 (0)7936 362586

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFEFSUEESEEL
Date   Source Headline
29th Jul 20217:00 amRNSHalf-year Report
22nd Jul 20217:40 amRNSNotice of Results
13th Jul 20217:00 amRNSRefinancing of Pinnacle Debt
8th Jul 20212:54 pmRNSHolding(s) in Company
1st Jul 202112:51 pmRNSTotal Voting Rights
1st Jul 202112:49 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSAcquisition of Joint Venture Interest
29th Jun 202110:38 amRNSHolding(s) in Company
15th Jun 20218:00 amRNSAdditional Listing
4th Jun 202111:19 amRNSHolding(s) in Company
4th Jun 202111:15 amRNSTotal Voting Rights
20th May 20218:00 amRNSHolding(s) in Company
5th May 202112:09 pmRNSHolding(s) in Company
5th May 20218:00 amRNSTotal Voting Rights
4th May 20219:30 amRNSNotice of Change to Director Details
29th Apr 202110:01 amRNSHolding(s) in Company
28th Apr 20218:00 amRNSAdditional Listing
23rd Apr 20213:12 pmRNSHolding(s) in Company
21st Apr 20212:00 pmRNSResult of AGM
21st Apr 20217:00 amRNSTrading Update
15th Apr 20219:29 amRNSHolding(s) in Company
13th Apr 20218:00 amRNSCompletion of acquisition
8th Apr 202110:08 amRNSHolding(s) in Company
7th Apr 20217:11 amRNSSatisfied conditions for proposed acquisition
1st Apr 20214:00 pmRNSBlock listing Interim Review - DSP
1st Apr 20213:58 pmRNSBlock listing Interim Review - PSP
1st Apr 20213:55 pmRNSBlock listing Interim Review - Sharesave
1st Apr 20212:10 pmRNSTotal Voting Rights
1st Apr 20212:01 pmRNSDirector/PDMR Shareholding
31st Mar 20215:03 pmRNSResult of Meeting
18th Mar 20219:00 amRNSMailing of Annual Report and Notice of AGM
12th Mar 202112:51 pmRNSProposed acquisition by Drax Group
11th Mar 20217:00 amRNSCapacity Market Agreements
9th Mar 20219:30 amRNSDirector/PDMR Shareholding
3rd Mar 20214:09 pmRNSHolding(s) in Company
2nd Mar 20214:19 pmRNSTotal Voting Rights
25th Feb 20217:00 amRNSAnnual Financial Report
24th Feb 202112:22 pmRNSHolding(s) in Company
17th Feb 20219:13 amRNSNotice of Results
16th Feb 20217:00 amRNSHolding(s) in Company
11th Feb 20214:41 pmRNSHolding(s) in Company
8th Feb 20217:00 amRNSProposed acquisition of Pinnacle Renewable Energy
5th Feb 20212:10 pmRNSHolding(s) in Company
3rd Feb 202111:18 amRNSTotal Voting Rights
1st Feb 20217:00 amRNSCompletion of sale of gas assets
29th Jan 20218:00 amRNSAdditional Listing
4th Jan 20212:34 pmRNSHolding(s) in Company
4th Jan 20212:27 pmRNSTotal Voting Rights
15th Dec 20207:45 amRNSSale of gas assets
1st Dec 20203:32 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.